Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of trastuzumab plus vinorelbine in HER2-positive metastatic breast cancer with cardiac disease
2010-018324-13Phase 2Terminated
- Sponsor
- Consorzio per la Ricerca Oncologica
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in HER2-positive breast cancer comparing Trastuzumab + vinorelbine with Vinorelbine alone (2 arms). Started Mar 2010; status: terminated.
02
Drugs
trastuzumabvinorelbine
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on 2010-018324-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018324-13.